Results 181 to 190 of about 95,563 (285)

Treatment of patients with prolactinomas [PDF]

, 1978
Fahlbusch, R., Landgraf, R., Pickardt, C. R., Rjosk, H. K., Scriba, Peter Christian, Werder, Klaus von   +5 more
core   +1 more source

Hypoxia-Induced Ferroptosis Resistance Drives Orbital Fibrosis in Thyroid Eye Disease. [PDF]

Invest Ophthalmol Vis Sci
Gong C, Liu S, Zhao J, Zhu J, Xing C, Li K, Xie C, Wu N, Chen R.   +8 more
europepmc   +1 more source

Anti‐inflammatory effects of physical stimuli: The central role of networks in shaping the future of pharmacological research

British Journal of Pharmacology, Volume 183, Issue 10, Page 2177-2196, May 2026.
Addressing complexity in the study of life sciences through Systems Biology and Systems Medicine has been transformative, making Systems Pharmacology the next logical step. In this review, we focus on physical stimuli, whose potential in pharmacology has been neglected, despite demonstrated therapeutic properties.
Veronica Paparozzi, Reyhaneh Hooshmandabbasi, Alessandro Ravoni, Ying Ma, Luigi Manni, Timothy J. Koh, Caroline Maake, Tiziana Guarnieri, Darong Lai, Vitalii Zablotskii, Christine Nardini   +10 more
wiley   +1 more source

Dissociation of stimulatory effects of cortocotrophin on adrenal corticosterone and protein synthesis following hypophysectomy [PDF]

, 1968
Kluge, F., Scriba, Peter Christian
core  

Teprotumumab N01 for thyroid eye disease in China: clinical outcomes and quantitative MRI correlations. [PDF]

Front Med (Lausanne)
Wang Q, Cheng J, Yang C, Song J, Chen Y, Shen Y, Qu L, Wei R.   +7 more
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Chronic pentamidine aerosol prophylaxis does not induce QT-prolongation and vetricular arrythmias [PDF]

, 1993
Bogner, Johannes R., Lohmöller, G., Thalhammer, C.   +2 more
core   +1 more source

Quantification of enlargement of the levator palpebrae superioris muscle in thyroid eye disease. [PDF]

Int Ophthalmol
Hains L, Rana K, Almater A, Patel S, Selva D.   +4 more
europepmc   +1 more source

THE EYE AND ORBIT IN THYROID DISEASE

Optometry and Vision Science, 1985
openaire   +2 more sources

Exploring the Role of Nocturnal Hypoxemia and Sleep Fragmentation in Memory Decline: Insights From Explainable Machine Learning Models

The Clinical Respiratory Journal, Volume 20, Issue 5, May 2026.
This graphical abstract illustrates the study workflow from polysomnography (PSG) data collection to explainable machine learning analysis and cognitive outcomes. Left: PSG monitoring captures nocturnal physiological signals including airflow and oxygen saturation. Center: Explainable AI (XRT algorithm) and SHAP analysis identify spontaneous NREM micro‐
Xin Li, Yingying Zhu, Fansu Meng, Kangan Lai, Yuling Liang, Huang Ting, Zhengnan Mai, Liang Li   +7 more
wiley   +1 more source